# A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer

> **NCT00114946** · PHASE4 · TERMINATED · sponsor: **Genentech, Inc.** · enrollment: 800 (—)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Avastin

## Key facts

- **NCT ID:** NCT00114946
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 800 (—)
- **Last updated:** 2006-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114946, "A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT00114946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*